Phase 4 Studies / Cases--AAO DME in the Real World: Treatments Past, Present, and Future Pre-test

Dexamethasone intravitreal implant (DEX) has shown efficacy in patients with diabetic macular edema (DME) in controlled trials
In the Reinforce Study what is the mean number of Dexamethasone implant injections given per year?
A 73 year old female, diagnosed with type 2 diabetes 14 years ago, presents with DME OD and 20/80 vision. She is started on Anti-VEGF medication and after each injection her edema decreases and vision improves.  However the retina remains dry for approximately one month which causes the edema to return and her vision to decrease. The swelling reoccurred and she was scheduled for anti-VEGF injections. The patient missed her appointment due to a trip to the emergency room where she reported her face sagged for 4 hours. At this time ER doctors were unsure if the cause was TIA or mild CVA. What would you do?
In the Clinical Trial Examining Patient Appointment Compliance Trends?
Vision loss in Wet AMD is usually rapid, central, and devastating?